GSDME and cancer: While these caspases can dismantle the cell to limit its immunogenic potential, caspase-3 has recently been documented to cleave (at 267 DMPD 270) and activate GSDME (or DFNA5, deafness autosomal dominant 5), a gene implicated in hearing loss and often silenced in cancer [103,104].